Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters

被引：0
|
作者：
Benjamin Stolte
Michael Nonnemacher
Kathrin Kizina
Saskia Bolz
Andreas Totzeck
Andreas Thimm
Bernd Wagner
Cornelius Deuschl
Christoph Kleinschnitz
Tim Hagenacker
机构：
[1] University Hospital Essen,Department of Neurology
[2] University Hospital Essen,Institute for Medical Informatics, Biometrics and Epidemiology
[3] University Hospital Essen,Department of Clinical Chemistry
[4] University Hospital Essen,Institute for Diagnostic and Interventional Radiology and Neuroradiology
[5] University Hospital Essen,Center for Translational and Behavioral Neuroscience
来源：
Journal of Neurology | 2021年 / 268卷
关键词：
ASO; Platelets; Kidney; Liver; Coagulation; Toxicity; Side effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4667 / 4679
页数：12
相关论文
共 50 条
  • [1] Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parameters
    Stolte, Benjamin
    Nonnemacher, Michael
    Kizina, Kathrin
    Bolz, Saskia
    Totzeck, Andreas
    Thimm, Andreas
    Wagner, Bernd
    Deuschl, Cornelius
    Kleinschnitz, Christoph
    Hagenacker, Tim
    JOURNAL OF NEUROLOGY, 2021, 268 (12) : 4667 - 4679
  • [2] Safety analysis of laboratory parameters in paediatric patients with spinal muscular atrophy treated with nusinersen
    Zhu, Xiaomei
    Li, Hui
    Hu, Chaoping
    Wu, Min
    Zhou, Shuizhen
    Wang, Yi
    Li, Wenhui
    BMC PEDIATRICS, 2024, 24 (01)
  • [3] Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy
    Stolte, Benjamin
    Totzeck, Andreas
    Kizina, Kathrin
    Bolz, Saskia
    Pietruck, Lena
    Moenninghoff, Christoph
    Guberina, Nika
    Oldenburg, Denise
    Forsting, Michael
    Kleinschnitz, Christoph
    Hagenacker, Tim
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [4] Experience of nusinersen treatment to adult patients with spinal muscular atrophy
    Saito, T.
    Matsuoka, Y.
    Odani, H.
    Matsumura, T.
    Nishio, H.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S137 - S138
  • [5] The Effect of Nusinersen Therapy on Laboratory Parameters of Patients with Spinal Muscular Atrophy
    Uzan, Gamze Sarikaya
    Paketci, Cem
    Gunay, Cagatay
    Edem, Pinar
    Ozsoy, Ozlem
    Kurul, Semra Hiz
    Yis, Uluc
    NEUROPEDIATRICS, 2022, 53 (05) : 321 - 329
  • [6] NUSINERSEN IN ADULT SPINAL MUSCULAR ATROPHY PATIENTS
    Fadia, Mithila
    Shroff, Sheetal
    Simpson, Ericka
    MUSCLE & NERVE, 2019, 60 : S54 - S54
  • [7] Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy
    Castanon, Felix Guerra
    Deardorff, Adam
    Zhao, Songzhu
    Severyn, Steven
    Kelly, Kristrina
    Tellez, Marco
    Heintzman, Sarah
    Sterling, Gary
    Kolb, Stephen
    Arnold, David
    Elsheikh, Bakri
    NEUROLOGY, 2023, 100 (17)
  • [8] Nusinersen treatment in adult patients with 5q spinal muscular atrophy
    Vazquez Costa, J.
    Monica, P.
    Nascimento, A.
    Kapetanovic, S.
    Moreno, A.
    Hervas, D.
    Pitarch, I.
    Nungo Garzon, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 832 - 832
  • [9] Nusinersen: A Treatment for Spinal Muscular Atrophy
    Claborn, Melanie K.
    Stevens, Debra L.
    Walker, Cheri K.
    Gildon, Brooke L.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (01) : 61 - 69
  • [10] NUSINERSEN IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY
    Sinko Gabriella
    Kiss Zsuzsanna
    Kalman Bernadette
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2018, 71 (3-4): : 90 - 94
12345